reversion to susceptibility are very slim. In the pre and post treatment stool cultures, all larvae obtained were classified as cyathostomes. Benzimidazoles resistance is widespread in the central area of Argentina [3] . In this context, the use of these drugs to control small strongyles could be currently inadvisable unless controls are carried out post treatment to establish efficacy thereof. Practitioners need to determine if anthelmintic resistance is present before advice control parasite programs. Presently, FECRT is the most appropriate method for these practices and should be used regularly to monitor the resistance status on horse farms. albiventris) hunted by dogs in a farm from the central region of Buenos Aires province were collected. Horses raised in the farm showed a 50% (10/20) S. neurona seroprevalence. One seropositive horse developed neurological signs and evidenced clinical improvement after a 2 month treatment with Ponazuril. A complete necropsy of the opossum was conducted and the intestinal mucosal scraping was subjected to a parasitological study with sucrose solution. A high amount of Sarcocystis spp. oocysts/sporocysts were observed (Fig. 1) . DNA was extracted from concentrated oocysts with a commercial kit (ZR Fecal DNA, Zymo Research). The sample was identified as S. neurona by specific PCR-restriction fragment length polymorphism (RFLP) and by sequencing of a fragment of the 18S rRNA gene. Approximately 5 x 10 5 oocysts were subjected to a pepsin-HCl digestion followed by a physical disruption. Released sporozoites were used to infect fresh BM cell cultures, maintained by 3 passages during 2 months and further preserved in liquid nitrogen. This study represents the first isolation of S. neurona in Argentina. Further studies will be conducted in order to identify antigen expression as well as to compare genetic characteristics between the isolated strain and reference strains. . The results of these investigations are summarized in Table 1 . As seen from the Table, 8 sera reacted with different titres against different T. equiperdum strains as well as T. evansi. This proves that standardization of T. equiperdum antigen for use in CFT is an important issue.
Acnowledgements
*The optimum dilution of T. evansi antigen for CFT testing has been obtained by performing checker board with T. evansi positive serum **The optimum dilution of different isolates of T. equiperdum antigen for CFT testing has been obtained by performing checker board with T. equiperdum positive serum. A molecular survey of equine piroplasms was conducted using samples collected from symptomatic and asymptomatic horses of Central Italy. Case definition for the acute form of piroplasmosis was temperature >38 C and at least one of the following signs, jaundice, anaemia and petechial haemorrhages, and a PCR positive result. Phylogenetic analysis was conducted on sequences of 78 blood samples collected in 2013/14, having either low Ct values in real-time PCRs (46 samples) for the parasites or a PCR pos/ ELISA neg (VMRD, USA) result (32 samples). Sequencing was performed on the V4 hypervariable region of the 18S rRNA gene which was 390 bp for B. caballi and 430 for T. equi [1, 2] . Using BLAST, sequences were aligned with those deposited in GenBank for both piroplasms, having a minimum 98% query coverage and >97% homology. Genetic distance and homology confirmed that sequences of both parasites could be divided into the 3 groups, with a homology among the groups >97% [1, 2]. Group 1 included sequences homologous to first-ever reported piroplasms, group 2 to the "like genotypes" [1] , and group 3 included those with equidistant homology for the two groups [2] . Among the 72 sequences identified as T. equi, 39 belonged to group 1, 24 to group 2, and 9 to group 3. Group 1 included 62% (24/39) of the sequences of symptomatic horses, while 96% (23/24) of T. equi like (group 2), were from asymptomatic horses. Studies report that sequences within group 1 and 2 are in all endemic areas, while in America only group 1 and 3 are present. To date, sequences belonging to Group 3 were never submitted for Europe and Asia. Of the 27 T. equi PCRpos/ELISAneg samples, 23 (85.1%) had Group 1 sequences with 19 of them from symptomatic horses. For B. caballi, 7 sequences were obtained, of which only 2 were from horses positive for ELISA, 4 belong to group 1, 1 to group 2, and 2 to group 3. No clinical significance was attributed to this parasite due to the limited number of sequences available. Sequences within the same groups and their wide geographic distribution suggest that the diversity could be independent from their origin and probably linked with the international movement of equidae. The present study is the first to report group 3 for both parasites Table 1 CFT results of 8 Dourine-positive Italian horse sera using T. evansi and different strains of T. equiperdum antigens SAMPLE ID CVRL CFT CFT CVRL CFT ** (with different T. equiperdum strains)
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